#COVID-19 vaccine

Research identifies most common symptoms and potential subgroups with the aim of improving future diagnostics and treatment.

Vaccine type, older age, male sex and especially smoking were associated with lower antibody responses.

Study suggests adults with both the sleep disorder and COVID-19 may benefit from clinical monitoring.

A booster targeting Omicron SARS-CoV-2 variant produced a broader immune response than one targeting variants similar to original strain.

For the millions who are more vulnerable to COVID, reliable data remains important for assessing safety.

Study findings suggest people with chronic liver disease should be prioritized for booster shots.

People 65 and older and immunocompromised people can get a second bivalent booster; most unvaccinated people now need only one initial shot.

Current vaccines are effective for preventing severe disease, but a nasal vaccine could potentially prevent infection and transmission.

The law define misinformation as false information that is contradicted by contemporary scientific consensus.

NIH-funded study suggests need to boost CD8+ T cell response after infection.

Experts stress the need for targeted efforts to increase vaccine uptake among cancer patients with lower vaccination rates.

People without insurance will need to either pay full price, seek free or low-cost vaccines from community clinics or go without.

Increased protection against hospitalization or death was seen regardless of age or history of previous boosters.

Young people help get COVID vaccination numbers up, particularly when they help navigate the health system for Spanish-speaking relatives.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.